These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2763305)

  • 1. Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
    Singh Y; Ulrich L; Katz D; Bowen P; Krishna G
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):9-23. PubMed ID: 2763305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G; Londos-Gagliardi D
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y; Park H; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C
    J Antibiot (Tokyo); 1989 Aug; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunomycin inhibits the uptake of adenine, amino acids, and glucose into cardiac myocytes.
    Reese JB; Shirhatti V; Singh Y; Krishna G
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):105-12. PubMed ID: 3564026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for inducing cardiotoxicity by anthracycline antibiotics: studies with neonatal rat cardiac myocytes in culture.
    Shirhatti V; George M; Chenery R; Krishna G
    Toxicol Appl Pharmacol; 1986 Jun; 84(1):173-91. PubMed ID: 3459265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
    Cini-Neri G; Neri B
    Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
    Swift L; McHowat J; Sarvazyan N
    Cancer Res; 2003 Sep; 63(18):5992-8. PubMed ID: 14522926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
    Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Konoshita M; Naganawa H; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1980 Dec; 33(12):1581-5. PubMed ID: 7195898
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
    Westendorf J; Groth G; Steinheider G; Marquardt H
    Cell Biol Toxicol; 1985 Jan; 1(2):87-101. PubMed ID: 3917129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.